The Use of Trichostatin A during Pluripotent Stem Cell Generation Does Not Affect MHC Expression Level

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Immunology

Background:

• Pluripotent stem cells (PSCs) hold promise for regenerative medicine.
• Efficient PSC generation and managing immunogenicity are key clinical challenges.
• Chromatin modulators like trichostatin A (TSA) may influence PSC characteristics.

Purpose of the Study:

• To investigate the effect of TSA on MHC molecule expression during PSC generation.
• To assess if TSA impacts the immunogenicity of generated PSCs.

Main Methods:

• Generated induced PSCs (iPSCs), NT-ESCs, and IVF-ESCs from mouse embryonic fibroblasts.
• Characterized PSCs using alkaline phosphatase assay, immunocytochemistry, and karyotyping.
• Quantified gene expression (pluripotency, HDACs, immune-related genes) via real-time PCR and analyzed surface MHC expression using flow cytometry.

Main Results:

• TSA (100 nM) significantly increased pluripotency markers (oct4, nanog, sox2, klf4).
• TSA (100 nM) upregulated H2db and downregulated H2-IE-bd in iPSCs.
• Overall MHC molecule expression remained largely unaffected by TSA in established PSC lines.

Conclusions:

• Short-term, low-concentration TSA treatment significantly enhances PSC generation efficiency.
• TSA does not adversely affect MHC expression profiles in established PSC lines.
• These findings support the potential clinical utility of TSA-assisted PSCs in regenerative medicine.